Catalyst Pharmaceuticals, Inc. (CPRX)
24.06
-0.29
(-1.19%)
USD |
NASDAQ |
Dec 29, 15:45
Catalyst Pharmaceuticals EPS Diluted (Quarterly): 0.4153 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Collegium Pharmaceutical, Inc. | 0.8385 |
| ACADIA Pharmaceuticals, Inc. | 0.4206 |
| Amicus Therapeutics, Inc. | 0.0558 |
| Rigel Pharmaceuticals, Inc. | 1.456 |
| Krystal Biotech, Inc. | 2.660 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 52.78M |
| Revenue (Quarterly) | 148.39M |
| Total Expenses (Quarterly) | 95.61M |
| Enterprise Value | 2.306B |
| Gross Profit Margin (Quarterly) | 78.44% |
| Profit Margin (Quarterly) | 35.57% |
| Earnings Yield | 7.12% |
| Operating Earnings Yield | 8.47% |
| Normalized Earnings Yield | 7.022 |